Selecting an anti-malarial clinical candidate from two potent dihydroisoquinolones
Background: The ongoing global malaria eradication campaign requires development of potent, safe, and cost-effective drugs lacking cross-resistance with existing chemotherapies. One critical step in drug development is selecting a suitable clinical candidate from late leads. Herein we present the pr...
Saved in:
Published in | Malaria Journal |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Web Resource |
Language | English |
Published |
Durham
Research Square
25.01.2021
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!